Aktis Oncology to Present at the Jefferies Global Healthcare Conference
Aktis Oncology announced that CEO Matthew Roden will present at the Jefferies Global Healthcare Conference on June 3, 2026. The presentation will likely cover the company's miniprotein radioconjugate platform and its clinical pipeline, including AKY-1189 and AKY-2519.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.